Azevan Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 27
Rang # Quantité totale PI 53 772
Note d'activité PI 1,6/5.0    7
Rang # Activité PI 134 662

Brevets

Marques

13 0
3 0
9 0
0
 
Dernier brevet 2024 - Compositions and methods for tre...
Premier brevet 2002 - Beta-lactamyl vasopressin v1a an...

Derniers inventions, produits et services

2023 Invention Compositions and methods for treating brain injury. Compounds, and compositions, methods, and us...
2022 Invention Compositions and methods for treating neurodegenerative diseases. Compounds, and compositions, m...
2019 Invention Compositions and methods for treating neurodegenerative diseases. Compounds, and compositions, me...
2018 Invention Compositions and methods for treating brain injury. Compounds, and compositions, methods, and use...
Invention Methods for treating post traumatic stress disorder. Compounds and compositions are described her...
2011 Invention Β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists. Substituted 2-(azetidin-2...
Invention Methods for treating post traumatic stress disorder. Compounds of the formula: (see above f...
2010 Invention Beta-lactamyl vasopressin v1a antagonists. Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivati...
2007 Invention {beta}-lactamyl vasopression v1a antagonists and methods of use. Novel 2-(azetidin-2-on-1-yl) al...
Invention {beta}-lactamyl vasopression v1a antagonists and methods of use. Novel 2-(azetidin-2-on-1-yl)alk...
Invention Beta-lactam cannabinoid receptor modulators. Described herein are substituted 2-(azetidin-2-on-1...
Invention Beta-lactam cannabinoid receptor modulators. Described herein are substituted 2-(azetidin-2-on-l-...
Invention Β -lactamyl vasopressin v2 antagonists. β-lactamyl alkanoic acids and pharmaceutical compositions...
Invention Hydroxy and keto-substituted β-lactamyl alkanedioic acids. 3-Hydroxy and 3-keto substituted ...
2006 Invention Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists. Substituted 2-(azetidi...
Invention Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists. Substituted 2-(a...
Invention 1a antagonists. 1a receptor
Invention Beta-lactamylalkanoic acids for treating premenstrual disorders. 0-lactamyl alkanoic acids are de...
Invention Beta-lactamylalkanoic acids. .beta.-lactamyl alkanoic acid vasopressin V1a receptor antagon...
Invention Beta-lactamyl vasopressin v1b antagonists. Substituted 2-(azetidin-2-on-l-yl)alkanedioic acids, s...
2004 Invention 3-substituted beta-lactamyl vasopressin v1a antagonists. Novel 2-(azetidin-2-on-1-yl)alkanedioic...
Invention 3-substituted &bgr;-lactamyl vasopressin v1a antagonists. Novel 2-(azetidin-2-on-1-yl)alkanedioic...
Invention 1a antagonists. 1a receptor.
2002 Invention Beta-lactamyl vasopressin v1a antagonists. Novel 2-(azetidin-2-on-1-yl)alkanedioic acid der...